Investment in Equity Securities - Additional Information (Details) - USD ($) $ / shares in Units, $ in Millions		1 Months Ended	3 Months Ended
	Jul. 01, 2021	Jul. 31, 2021	Mar. 31, 2022	Dec. 31, 2021	Jun. 30, 2021
Schedule Of Equity Method Investments [Line Items]
Common stock, shares outstanding (in shares)			49,854,631	49,800,756
Business combination percentage of share converted into and paid in cash	2.40%
Sharecare equity security, Cost basis	$ 10.5
Average cost per share	$ 0.95
Number of common stock shares permitted to sell			120,000,000	120,000,000
Unrealized loss			$ 22.4
Valuation allowance of deferred tax assets related to capital loss carryforwards				$ 135.4
Increase in valuation allowance of deferred tax assets related to capital loss carryforwards			$ 5.7
Period Between December 28, 2021 and March 27, 2022
Schedule Of Equity Method Investments [Line Items]
Number of common stock shares permitted to sell			750,000
Period Between March 28, 2022 and July 1, 2022
Schedule Of Equity Method Investments [Line Items]
Number of common stock shares permitted to sell			750,000
Legacy Sharecare
Schedule Of Equity Method Investments [Line Items]
Common stock, shares outstanding (in shares)					159,309
Sharecare
Schedule Of Equity Method Investments [Line Items]
Common stock, shares outstanding (in shares)		11,079,331
Business combination, cash received		$ 2.7